SLGL Stock Summary and Trading Ideas (Sol-Gel Technologies Ltd. - | NASDAQ:SLGL)

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.

Sol-Gel Technologies Ltd. - trades on the NASDAQ stock market under the symbol SLGL.

As of February 28, 2025, SLGL stock price climbed to $0.67 with 50,254 million shares trading.

SLGL has a market cap of $18.67 million. This is considered a Sub-Micro Cap stock.

Last quarter Sol-Gel Technologies Ltd. - reported $5 million in Revenue and -$.01 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.12.

In the last 3 years, SLGL traded as high as $7.95 and as low as $.33.

SLGL has underperformed the market in the last year with a return of -43.2%, while SPY returned +18.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in SLGL shares. However, SLGL has outperformed the market in the last 3 month and 2 week periods, returning +16.5% and +9.9%, while SPY returned -0.4% and -2.5%, respectively. This indicates SLGL has been having a stronger performance recently.

SLGL support price is $.53 and resistance is $.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SLGL shares will trade within this expected range on the day.